Fact Based List:
The 10 drugs for which companies spent the most in payments to physicians in 2015
Submitted by Anonymous on Wed, 12/14/2016 - 18:47
- Xarelto ($28.4 Million)
- Humira ($24.9 Million)
- Invokana ($20.9 Million)
- Viekira ($19.2 Million)
- Eliquis ($18.8 Million)
- Bydureon ($18.5 Million)
- Androgel ($15.3 Million)
- Synthroid ($14.7 Million)
- Lupron ($14.3 Million)
- Victoza ($11.9 Million)
Source: Pro Publica
Source URL: https://www.propublica.org/article/updated-dollars-for-docs-...
List Ratings: |
Lists You Might Also Be Interested In
- Doximity: 5 Cities Leading in Physician Compensation Growth in 2017
- 6 Takeaways from CMS Pitch on Physician Payment Rule for 2021
- Doximity: Percentage of Physician Interest in Telemedicine by Age Group
- Kathleen Harkins: Six reasons ACOs struggle with network physicians and recruitment efforts
- American College of Physicians: Recommendations for Ensuring Medicare’s Solvency, Reducing Costs, and Maintaining Access to Affordable Care for Beneficiaries
Login or register to post comments